Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

947507

	registered interest
	date	24/07/2018
	answering body	Department for Education
	answering dept id	60
	answering dept short name	Education
	answering dept sort name	Education
	hansard heading	Academies
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Education, what assessment he has made of the potential merits of providing for a route whereby schools in difficulty which have been converted to academy status can revert to local authority control; and if he will make a statement.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	168014
	answer	answer is ministerial correction date of answer 04/09/2018 answer text <p>We have no plans to consider returning schools back to local authorities.</p><p>Indeed, as of March 2018, over half a million pupils now study in sponsored academies that are rated Good or Outstanding; they typically replaced underperforming maintained schools.</p><p>The department firmly believe that becoming an academy can bring enormous benefits to schools and their pupils; coming together in a multi-academy trust, sharing expertise, working collaboratively, driving improvements.</p><p>Hundreds of schools every year continue to voluntarily choose to become an academy and join a multi academy trust.</p><p>The department is working on a range of methods and tools for building trust capacity and assessing risk.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 04/09/2018 09:42:34 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	3960 label Biography information for Henry Smith

872272

	registered interest
	date	26/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Acute Lymphoblastic Leukaemia: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the availability of treatments for patients diagnosed with Refractory B-cell Acute Lymphoblastic Leukaemia.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	134186
	answer	answer is ministerial correction date of answer 03/04/2018 answer text <p>The following treatments are routinely available, having undergone Technical Appraisals by the National Institute for Health and Care Excellence (NICE). They were previously accessible through the Cancer Drugs Fund.</p><p> </p><p>- Blinatumomab for relapsed refractory (r/r) Philadelphia negative acute lymphoblastic leukaemia (ALL); and</p><p>- Ponatinib for Philadelphia positive ALL in patients in whom imatinib is not clinically appropriate (which might cover some r/r).</p><p> </p><p>The following treatments are currently under consideration by NICE:</p><p> </p><p>- CAR-T (Tisagenlecleucel-T and also Axicabtagene ciloleucel) for previously treated B-cell ALL in people aged 3 to 21 at initial diagnosis;</p><p>- Inotuzumab ozogamicin for treating r/r ALL; and</p><p>- Blinatumomab in other extended indications in ALL.</p><p> </p><p>Finally, the following treatments are currently accessible through the Cancer Drugs Fund.</p><p> </p><p>- Clofarabine for treating ALL in children after two therapies; and</p><p>- Nelarabine for treating ALL after two therapies.</p><p> </p><p>Information on the number and proportion of patients with refractory B-cell Acute Lymphoblastic Leukaemia who have been unable to access treatments for that condition is not held centrally.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 134187 question first answered 03/04/2018 13:25:08 answering member 4067 label Biography information for Steve Brine
	tabling member	3960 label Biography information for Henry Smith

872273

	registered interest
	date	26/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Acute Lymphoblastic Leukaemia: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many and what proportion of patients with Refractory B-cell Acute Lymphoblastic Leukaemia have been unable to access treatments for that condition.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	134187
	answer	answer is ministerial correction date of answer 03/04/2018 answer text <p>The following treatments are routinely available, having undergone Technical Appraisals by the National Institute for Health and Care Excellence (NICE). They were previously accessible through the Cancer Drugs Fund.</p><p> </p><p>- Blinatumomab for relapsed refractory (r/r) Philadelphia negative acute lymphoblastic leukaemia (ALL); and</p><p>- Ponatinib for Philadelphia positive ALL in patients in whom imatinib is not clinically appropriate (which might cover some r/r).</p><p> </p><p>The following treatments are currently under consideration by NICE:</p><p> </p><p>- CAR-T (Tisagenlecleucel-T and also Axicabtagene ciloleucel) for previously treated B-cell ALL in people aged 3 to 21 at initial diagnosis;</p><p>- Inotuzumab ozogamicin for treating r/r ALL; and</p><p>- Blinatumomab in other extended indications in ALL.</p><p> </p><p>Finally, the following treatments are currently accessible through the Cancer Drugs Fund.</p><p> </p><p>- Clofarabine for treating ALL in children after two therapies; and</p><p>- Nelarabine for treating ALL after two therapies.</p><p> </p><p>Information on the number and proportion of patients with refractory B-cell Acute Lymphoblastic Leukaemia who have been unable to access treatments for that condition is not held centrally.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 134186 question first answered 03/04/2018 13:25:08 answering member 4067 label Biography information for Steve Brine
	tabling member	3960 label Biography information for Henry Smith

831192

	registered interest
	date	26/01/2018
	answering body	Home Office
	answering dept id	1
	answering dept short name	Home Office
	answering dept sort name	Home Office
	hansard heading	Airguns: Licensing
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for the Home Department, whether she plans to extend the gun licensing regime to air weapons that have a muzzle energy of more than one joule.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	125200
	answer	answer is ministerial correction date of answer 01/02/2018 answer text <p>We are reviewing the regulation of air weapons in England and Wales. We have asked for the views of interested parties by 6 February 2018 on a range of issues, including manufacturing standards, secure storage and whether current arrangements are sufficient to prevent children gaining access to air weapons. As part of the review, we are looking at the arrangements in Scotland and Northern Ireland where air weapons with a muzzle energy of more than one joule are subject to licensing regimes. We will publish the outcome of the review in due course.</p> answering member constituency Ruislip, Northwood and Pinner answering member printed Mr Nick Hurd question first answered 01/02/2018 17:30:35 answering member 1561 label Biography information for Mr Nick Hurd
	tabling member	3960 label Biography information for Henry Smith

836016

	registered interest
	date	02/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many emergency presentations there were of blood cancer; what proportion of those presentations were of all diagnoses of blood cancer; and what proportion those were of the total of all emergency presentations of cancer in each of the last five years for which figures are available.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	126371
	answer	answer is ministerial correction date of answer 08/02/2018 answer text <p>In 2015, the latest year for which data are available, the percentage of patients diagnosed after an emergency presentation in England for all blood cancers was 28% (7,626 of 26,869).</p><p> </p><p>There has been a fall in the percentage diagnosed through this emergency presentation route over the last 10 years for some of these cancers: chronic lymphocytic leukaemia (26% in 2006 down to 13% in 2015), multiple myeloma (37% down to 31%), and other haematological malignancies (37% down to 25%). The proportion over time in the other groups remained relatively stable.</p><p> </p><p>As a proportion of all emergency diagnoses, the proportion of blood cancers diagnosed as an emergency was 12% in 2011 and 13% in each of 2012-2015.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 126372 question first answered 08/02/2018 14:30:04 answering member 4067 label Biography information for Steve Brine
	tabling member	3960 label Biography information for Henry Smith

836017

	registered interest
	date	02/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of trends in the instances of blood cancer being diagnosed after an emergency admission; and if he will make a statement.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	126372
	answer	answer is ministerial correction date of answer 08/02/2018 answer text <p>In 2015, the latest year for which data are available, the percentage of patients diagnosed after an emergency presentation in England for all blood cancers was 28% (7,626 of 26,869).</p><p> </p><p>There has been a fall in the percentage diagnosed through this emergency presentation route over the last 10 years for some of these cancers: chronic lymphocytic leukaemia (26% in 2006 down to 13% in 2015), multiple myeloma (37% down to 31%), and other haematological malignancies (37% down to 25%). The proportion over time in the other groups remained relatively stable.</p><p> </p><p>As a proportion of all emergency diagnoses, the proportion of blood cancers diagnosed as an emergency was 12% in 2011 and 13% in each of 2012-2015.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 126371 question first answered 08/02/2018 14:30:04 answering member 4067 label Biography information for Steve Brine
	tabling member	3960 label Biography information for Henry Smith

836018

	registered interest
	date	02/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether diagnostic centres established as a result of the Cancer Strategy for England take specific account of blood cancer; and if he will make a statement.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	126373
	answer	answer is ministerial correction date of answer 08/02/2018 answer text <p>The wave two of the Accelerate, Coordination and Evaluation (ACE) programme is testing a new multi-disciplinary diagnostic centre approach to diagnosing patients with vague or unclear but concerning symptoms, often characteristic of hard to diagnose cancers like blood cancers. This approach aims to ensure that patients can receive a suite of tests, reducing the risk that patients receive multiple different referrals for the same problem. The ACE programme has established ten pilot Rapid Diagnostic Assessment Centres across five areas of the country.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/02/2018 15:33:52 answering member 4067 label Biography information for Steve Brine
	tabling member	3960 label Biography information for Henry Smith

836019

	registered interest
	date	02/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what proportion of people diagnosed with blood cancer have had access to a clinical nurse specialist in each of the last three years; and if he will make a statement.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	126374
	answer	answer is ministerial correction date of answer 08/02/2018 answer text <p>NHS England does not collect this information centrally.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/02/2018 14:39:50 answering member 4067 label Biography information for Steve Brine
	tabling member	3960 label Biography information for Henry Smith

836020

	registered interest
	date	02/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to include blood cancer diagnoses as part of the cancer dashboard.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	126375
	answer	answer is ministerial correction date of answer 08/02/2018 answer text <p>Public Health England and NHS England developed the first iteration of the cancer dashboard in response to recommendations in the Independent Cancer Taskforce report ‘Achieving world-class cancer outcomes: a strategy for England 2015-2020’. This includes data on breast, colorectal, lung and prostate cancers. Further cancer sites (including blood cancer) were not included because of the risk of making patients identifiable when viewing data for individual hospitals or clinical commissioning groups.</p><p> </p><p>A second iteration of the dashboard is being developed by NHS Digital and NHS England with a wider ambition to include rarer cancers and cancers with a lower incidence, such a blood cancers, as the dashboard develops.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/02/2018 14:41:34 answering member 4067 label Biography information for Steve Brine
	tabling member	3960 label Biography information for Henry Smith

836021

	registered interest
	date	02/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effectiveness of the National Institute for Health and Clinical Excellence guidance, Haematological cancers: Improving outcomes (NG 47); and if he will make a statement.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	126376
	answer	answer is ministerial correction date of answer 08/02/2018 answer text <p>Currently there has been no assessment of NG47.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/02/2018 14:38:00 answering member 4067 label Biography information for Steve Brine
	tabling member	3960 label Biography information for Henry Smith